{"id":"https://openalex.org/W3196536071","doi":"https://doi.org/10.1182/bloodadvances.2021005148","title":"Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials","display_name":"Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials","publication_year":2021,"publication_date":"2021-09-02","ids":{"openalex":"https://openalex.org/W3196536071","doi":"https://doi.org/10.1182/bloodadvances.2021005148","mag":"3196536071","pmid":"https://pubmed.ncbi.nlm.nih.gov/34473244","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8579250"},"language":"en","primary_location":{"id":"doi:10.1182/bloodadvances.2021005148","doi":"https://doi.org/10.1182/bloodadvances.2021005148","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2021005148","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/5/21/4352/1830711/advancesadv2021005148.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://ashpublications.org/bloodadvances/article-pdf/5/21/4352/1830711/advancesadv2021005148.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069251789","display_name":"Andrew Hantel","orcid":"https://orcid.org/0000-0001-9612-3643","observed_orcids":["https://orcid.org/0000-0001-9612-3643"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew Hantel","raw_affiliation_strings":["Center for Bioethics, Harvard Medical School, Boston, MA;","Division of Inpatient Oncology, Dana-Farber Cancer Institute, Boston, MA;","Division of Population Sciences and"],"raw_orcid":"https://orcid.org/0000-0001-9612-3643","affiliations":[{"raw_affiliation_string":"Center for Bioethics, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Division of Inpatient Oncology, Dana-Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Division of Population Sciences and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023296232","display_name":"Marlise Rachael Luskin","orcid":"https://orcid.org/0000-0002-5781-4529","observed_orcids":["https://orcid.org/0000-0002-5781-4529"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marlise R. Luskin","raw_affiliation_strings":["Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA; and"],"raw_orcid":"https://orcid.org/0000-0002-5781-4529","affiliations":[{"raw_affiliation_string":"Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA; and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102705548","display_name":"Jacqueline Suen Garcia","orcid":"https://orcid.org/0000-0003-2118-6302","observed_orcids":["https://orcid.org/0000-0003-2118-6302","https://orcid.org/0000-0002-2599-7308"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacqueline S. Garcia","raw_affiliation_strings":["Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA; and"],"raw_orcid":"https://orcid.org/0000-0003-2118-6302","affiliations":[{"raw_affiliation_string":"Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA; and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005939966","display_name":"Wendy Stock","orcid":"https://orcid.org/0000-0002-8349-9200","observed_orcids":["https://orcid.org/0000-0002-8349-9200"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wendy Stock","raw_affiliation_strings":["Division of Oncology, The University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Oncology, The University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082924494","display_name":"Daniel J. DeAngelo","orcid":"https://orcid.org/0000-0001-7865-2306","observed_orcids":["https://orcid.org/0000-0001-7865-2306"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel J. DeAngelo","raw_affiliation_strings":["Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA; and"],"raw_orcid":"https://orcid.org/0000-0001-7865-2306","affiliations":[{"raw_affiliation_string":"Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA; and","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5091710463","display_name":"Gregory Alan Abel","orcid":"https://orcid.org/0000-0003-1100-2813","observed_orcids":["https://orcid.org/0000-0003-1100-2813"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gregory A. Abel","raw_affiliation_strings":["Center for Bioethics, Harvard Medical School, Boston, MA;","Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA; and","Division of Population Sciences and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Bioethics, Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984"]},{"raw_affiliation_string":"Division of Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA; and","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Division of Population Sciences and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5091710463"],"corresponding_institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"],"apc_list":{"value":3800,"currency":"USD","value_usd":3800},"apc_paid":{"value":3800,"currency":"USD","value_usd":3800},"fwci":4.8218,"has_fulltext":true,"cited_by_count":41,"citation_normalized_percentile":{"value":0.95819459,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"5","issue":"21","first_page":"4352","last_page":"4360"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.9297000169754028,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.01549999974668026,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10843","display_name":"Diversity and Career in Medicine","score":0.01119999960064888,"subfield":{"id":"https://openalex.org/subfields/3318","display_name":"Gender Studies"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/racial-and-ethnic-disparities","display_name":"racial and ethnic disparities","score":0.8410000205039978},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.781000018119812},{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9869999885559082},{"id":"https://openalex.org/keywords/clinicaltrials-gov","display_name":"ClinicalTrials.gov","score":0.8849999904632568},{"id":"https://openalex.org/keywords/hispanic-patients","display_name":"Hispanic patients","score":0.7020000219345093},{"id":"https://openalex.org/keywords/black-patients","display_name":"Black patients","score":0.902999997138977},{"id":"https://openalex.org/keywords/native-american-patients","display_name":"Native American patients","score":0.8500000238418579},{"id":"https://openalex.org/keywords/asian-patients","display_name":"Asian patients","score":0.9599999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7557451128959656},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.7337267398834229},{"id":"https://openalex.org/C137403100","wikidata":"https://www.wikidata.org/wiki/Q41710","display_name":"Ethnic group","level":2,"score":0.6691300868988037},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5657493472099304},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.5163175463676453},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.47954651713371277},{"id":"https://openalex.org/C143095724","wikidata":"https://www.wikidata.org/wiki/Q515895","display_name":"Odds","level":3,"score":0.4729211926460266},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.4672076106071472},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.4671330749988556},{"id":"https://openalex.org/C76509639","wikidata":"https://www.wikidata.org/wiki/Q918036","display_name":"Race (biology)","level":2,"score":0.4463646113872528},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42855334281921387},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.2273215353488922},{"id":"https://openalex.org/C59822182","wikidata":"https://www.wikidata.org/wiki/Q441","display_name":"Botany","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C19165224","wikidata":"https://www.wikidata.org/wiki/Q23404","display_name":"Anthropology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001741","descriptor_name":"Black or African American","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005006","descriptor_name":"Ethnicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006630","descriptor_name":"Hispanic or Latino","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008913","descriptor_name":"Minority Groups","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D015470","descriptor_name":"Leukemia, Myeloid, Acute","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1182/bloodadvances.2021005148","doi":"https://doi.org/10.1182/bloodadvances.2021005148","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2021005148","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/5/21/4352/1830711/advancesadv2021005148.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:7471486","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC8579250","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:8579250","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8579250","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Adv","raw_type":"Text"},{"id":"pmid:34473244","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34473244","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood advances","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1182/bloodadvances.2021005148","doi":"https://doi.org/10.1182/bloodadvances.2021005148","is_oa":true,"landing_page_url":"https://doi.org/10.1182/bloodadvances.2021005148","pdf_url":"https://ashpublications.org/bloodadvances/article-pdf/5/21/4352/1830711/advancesadv2021005148.pdf","source":{"id":"https://openalex.org/S2764683450","display_name":"Blood Advances","issn_l":"2473-9529","issn":["2473-9529","2473-9537"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9629999995231628,"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10"},{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G7262171246","display_name":"SPORE in Myeloid Malignancies","funder_award_id":"P50CA206963","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000070958","display_name":null,"funder_award_id":"CA206963","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000879495","display_name":"Training in Oncology Population Sciences (TOPS)","funder_award_id":"T32CA092203","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000889887","display_name":"Development of Novel Therapeutic Strategies in Human Leukemias","funder_award_id":"P01CA066996","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306085","display_name":"U.S. Department of Health and Human Services","ror":"https://ror.org/033jnv181"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3196536071.pdf","grobid_xml":"https://content.openalex.org/works/W3196536071.grobid-xml"},"referenced_works_count":32,"referenced_works":["https://openalex.org/W1843486339","https://openalex.org/W1968753932","https://openalex.org/W1981182751","https://openalex.org/W1998400196","https://openalex.org/W2031317733","https://openalex.org/W2033865107","https://openalex.org/W2040838599","https://openalex.org/W2064312699","https://openalex.org/W2074048861","https://openalex.org/W2134119631","https://openalex.org/W2142389745","https://openalex.org/W2170566133","https://openalex.org/W2519918803","https://openalex.org/W2613736770","https://openalex.org/W2737749411","https://openalex.org/W2762869808","https://openalex.org/W2766892297","https://openalex.org/W2786431998","https://openalex.org/W2800479580","https://openalex.org/W2803975317","https://openalex.org/W2892265211","https://openalex.org/W2945419414","https://openalex.org/W2945629358","https://openalex.org/W2969249951","https://openalex.org/W2991619365","https://openalex.org/W3000086280","https://openalex.org/W3087595029","https://openalex.org/W3095920672","https://openalex.org/W3108214625","https://openalex.org/W3165809157","https://openalex.org/W4240338964","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W3195285167","https://openalex.org/W3171076522","https://openalex.org/W4415791945","https://openalex.org/W4389233600","https://openalex.org/W4406732078","https://openalex.org/W3211808756","https://openalex.org/W4405039506","https://openalex.org/W7084040388","https://openalex.org/W4389220425","https://openalex.org/W4417005140"],"abstract_inverted_index":{"Data":[0],"regarding":[1],"racial":[2],"and":[3,12,25,46,51,68,79,89,97,104,119,142,151,216,221,229,235,272],"ethnic":[4],"enrollment":[5,47,93,125,218,246,266,273],"diversity":[6,48,69,256],"for":[7,49,132,248],"acute":[8,13,249,278],"myeloid":[9],"leukemia":[10,15,250,279],"(AML)":[11],"lymphoid":[14],"(ALL)":[16],"clinical":[17],"trials":[18,53,78,82,100,160,251],"in":[19,37,54,66,255],"the":[20,30,38,55,168,199,258],"United":[21,56],"States":[22,57],"are":[23,282],"limited,":[24],"little":[26],"is":[27,252],"known":[28],"about":[29],"effect":[31],"of":[32,159,167,193,219],"federal":[33],"reporting":[34,45,67,71,161,169,179,200,247,259],"requirements":[35,72,170,201,260],"instituted":[36,203],"late":[39],"2000s.":[40],"We":[41],"examined":[42],"demographic":[43,245],"data":[44,242],"ALL":[50,81,145,231],"AML":[52,77],"from":[58],"2002":[59],"to":[60,172,183,191,206,210,264,277],"2017,":[61],"as":[62,64],"well":[63],"changes":[65,254],"after":[70,130,165,198,257],"were":[73,202,269],"instituted.":[74],"Of":[75],"223":[76],"97":[80],"with":[83,127],"results":[84],"on":[85],"ClinicalTrials.gov,":[86],"68":[87],"(30.5%)":[88],"51":[90],"(52.6%)":[91],"reported":[92,102],"by":[94],"both":[95,237],"race":[96,103,162],"ethnicity.":[98],"Among":[99],"that":[101,244,268],"ethnicity":[105],"(AML,":[106],"n":[107,111],"=":[108,112,175,186],"6554;":[109],"ALL,":[110],"4149),":[113],"non-Hispanic":[114],"(NH)-Black,":[115],"NH-Native":[116],"American,":[117],"NH-Asian,":[118],"Hispanic":[120,222],"patients":[121,129,194,223],"had":[122],"significantly":[123,164,197],"lower":[124],"compared":[126],"NH-White":[128],"adjusting":[131],"race-ethnic":[133],"disease":[134],"incidence":[135],"(AML":[136,225],"odds":[137,146,226,232],"ratio,":[138,147,227,233],"0.68,":[139],"0.31,":[140],"0.75,":[141],"0.83,":[143],"respectively;":[144],"0.74,":[148],"0.27,":[149],"0.67,":[150],"0.64;":[152],"all,":[153],"P":[154,174,185,213,238],"\u2264":[155,239],".01).":[156,240],"The":[157],"proportion":[158],"increased":[163,196],"implementation":[166],"(44.2%":[171],"60.2%;":[173],".02),":[176],"but":[177],"race-ethnicity":[178],"did":[180],"not":[181],"(34.8%":[182],"38.6%;":[184],".57).":[187],"Reporting":[188],"proportions":[189],"according":[190],"number":[192],"enrolled":[195],"(race,":[204],"51.7%":[205],"72.7%;":[207],"race-ethnicity,":[208],"39.5%":[209],"45.4%;":[211],"both,":[212],"<":[214],".001),":[215],"relative":[217],"NH-Black":[220],"decreased":[224],"0.79":[228],"0.77;":[230],"0.35":[234],"0.25;":[236],"These":[241],"suggest":[243],"suboptimal,":[253],"may":[261],"be":[262],"due":[263],"additional":[265],"disparities":[267],"previously":[270],"unreported,":[271],"diversification":[274],"strategies":[275],"specific":[276],"care":[280],"delivery":[281],"needed.":[283]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-09-13T00:00:00"}